Indonesia is pursuing financial sustainability for its immunization services through legislation and expenditure tracking. The Sabin Sustainable Immunization Financing (SIF) Program began its efforts in Indonesia in July 2013.
Immunization Program Structure
Indonesia’s National Immunization Program (NIP) is located in the Immunization and Quarantine Directorate, Division of Communicable Disease Control and Environmental Health, Ministry of Health (MOH).
Indonesia’s Progress to Date
Over the period 2006-2014, Indonesia’s Gross National Income rose from US$1,390 to $3,650 per capita, a 163% increase. According to the WHO/UNICEF Joint Reporting Form (JRF), the Indonesian government spent $8 on routine immunization per surviving infant in 2006. By 2014, this figure had risen to $9, a 13% increase. While increasing in absolute terms, the government share of total routine immunization expenditures dropped from 95% to 64% over the period. Since 2010, Indonesia has reported inconsistently on JRF financial indicators. The data suggest that Indonesia has progressed towards country ownership of its immunization program. Among SIF countries, Indonesia ranked tenth in terms of routine immunization spending per surviving infant in 2014.
The Indonesian Health Law was passed in 2009. In November 2014, the MOH and Ministry of Planning (MOP) began reviewing all immunization-related legislation.
Beginning in July 2014, the MOF and UNICEF conducted a four-district costing study in East Java.
- July 2014: Indonesian counterparts join Cambodian, Mongolian, Nepali and Sri Lankan delegates in a Sabin-sponsored peer review workshop
- November 2013: Indonesian counterparts join Vietnamese and Mongolian delegates in Sabin-sponsored peer exchange
- August 2013: Indonesian counterparts attend Sabin-sponsored colloquium
- July 2013: Senior Program Officer and Program Director introduce SIF program to Indonesian government